Investor Relations

Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).

Share price

Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD

Latest financial report
Interim Report Q4 2020, incl. Full Year Report, Jan. 28

PDF     |     AudioCast      |     Presentation

APRIL 13, 2021
Report from the Annual General Meeting

Latest CEO Comments

JANUARY 28, 2021

"Progress while adjusting to new market dynamics"

Read the latest CEO comments from Nikolaj Sørensen

News flow

Regulatory Press Releases

Key financial figures

Group net revenue

663.6 MSEK
Last Twelve Months, Q120-Q420

Group EBITDA

19.0 MSEK
Last Twelve Months, Q120-Q420

US Pharma segment EBIT

331.2 MSEK
Last Twelve Months, Q120-Q420

Cash position

505.3 MSEK
Q420
IR-Contact